# Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients

> **NCT06309251** · — · RECRUITING · sponsor: **Danone Nutricia SpA Società Benefit** · enrollment: 100 (estimated)

## Conditions studied

- Drug Resistant Epilepsy
- Autism Spectrum Disorder
- Chronic Migraine
- Brain Tumor, Pediatric

## Interventions

- **OTHER:** ketogenic diet (as per clinical practice)

## Key facts

- **NCT ID:** NCT06309251
- **Lead sponsor:** Danone Nutricia SpA Società Benefit
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06309251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06309251, "Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06309251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*